covid-19

JJ COVID Vaccine Extension

Important Information regarding Janssen/Johnson & Johnson (J&J) COVID-19 Vaccine   On July 13, 2021, the U.S. Food and Drug Administration (FDA) announced revisions to the Emergency Use Authorization (EUA) fact sheets for the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine to include information regarding an observed increased risk of Guillain-Barre Syndrome (GBS) after administration of the vaccine.

By |2022-09-21T19:46:06+00:00June 15th, 2021|Covid Resources|0 Comments

“Universal Dose” Administration Process

Dear Enrolled Provider:  Effective today, May 11th, New York State is moving to a “Universal Dose” administration process for all multi-dose COVID-19 vaccine types. All doses are now considered universal doses, which means that doses can be used for a first dose or a second dose, irrespective as to whether they were originally shipped to providers as a first dose or a second dose. First and

By |2022-09-21T19:45:30+00:00May 11th, 2021|Covid Resources|0 Comments

NYS DOH Commissioner has released a statement regarding the Johnson & Johnson vaccine

NYS Department of Health Commissioner Dr. Howard Zucker released the following statement regarding the Johnson & Johnson vaccine: "Today the CDC and FDA issued a statement recommending a pause in the use of the Johnson & Johnson vaccine out of an abundance of caution. New York State will follow the CDC and FDA recommendation and pause the use

By |2022-09-21T19:45:11+00:00April 13th, 2021|Covid Resources|0 Comments

NYS Physicians Practices Begin to Receive COVID-19 Vaccine

NYS Physicians Practices Begin to Receive COVID-19 Vaccine  Physicians are Encouraged to Take NYS DOH Survey   Today, the Medical Society of the State of New York was notified by the New York State Department of Health that 27,100 Moderna doses were allocated to 190 enrolled COVID-19 providers. All physicians and other providers that pre-booked

By |2022-09-21T19:44:41+00:00March 22nd, 2021|Covid Resources|0 Comments

NYS DOH Informational Message: Monoclonal Antibodies

NYS DOH Informational Message: Monoclonal Antibodies   Monoclonal antibody treatments for COVID-19 are no longer being distributed through a state allocation system. There is no shortage in supply of these drugs, and the U.S. Department of Health and Human Services (HHS) has enough on hand to meet the needs of all treatment facilities. For this reason,

By |2022-09-21T19:44:16+00:00March 19th, 2021|Covid Resources|0 Comments

Important Update to NYS Vaccine Tracker Reporting

Important Update to NYS Vaccine Tracker Reporting   Effective immediately, providers in receipt of COVID-19 vaccine, irrespective as to whether such doses are via a direct State or federal allocation or a redistribution, will now be required to report to the vaccine tracker on Mondays and Thursdays by 10am. All providers with COVID-19 vaccine doses on hand or that depleted their allocation since their

By |2022-09-21T19:43:50+00:00March 16th, 2021|Covid Resources|0 Comments

Vaccine Supply Issues

Dear NYS COVID-19 Vaccine Provider: This email includes updated information about submission of weekly planning requests (“prebook requests”) for COVID-19 vaccine for your provider location enrolled in the NYSDOH COVID-19 Vaccine Program to include Janssen (Johnson and Johnson) vaccine. The requests are always due by 5 pm each Monday and must be data entered in NYSIIS on Monday (and not in advance). 

By |2022-09-21T19:43:27+00:00March 1st, 2021|Covid Resources|0 Comments

Update: Weekely Planning Requests for COVID-19 Vaccines

Dear NYS COVID-19 Vaccine Provider: This email includes clarifying information about submitting weekly planning requests for COVID-19 vaccine for your provider location enrolled in the NYSDOH COVID-19 Vaccine Program. The process for submitting a planning request is currently called “prebooking” in NYSIIS. We are hearing that the term “prebooking” is confusing to some so we

By |2022-09-21T19:43:01+00:00January 25th, 2021|Covid Resources|0 Comments
Go to Top